[ Price : $8.95]
Bracco Diagnostics recalls nine lots of Isovue pre-filled syringes due to the presence of visible particles.[ Price : $8.95]
FDA accepts an Aveo Oncology and Astellas Pharma NDA for tivozanib, indicated for treating patients with advanced renal cell carci...[ Price : $8.95]
Endo asks FDA to act quickly in determining that its non-crush resistant Opana ER was withdrawn from the market for reasons of saf...[ Price : $8.95]
Forest Laboratories submits an NDA for cariprazine, indicated for treating schizophrenia and manic or mixed episodes associated wi...[ Price : $8.95]
Ropes & Gray attorneys say two HHS Inspector General roundtables this year on pharmaceutical company compliance with corporate int...[ Price : $8.95]
FDA reports on enforcement actions taken against 17 classes of unapproved new drugs.[ Price : $8.95]
The HHS inspector general says it has recovered about $6.9 billion through FY 2012 investigations and audits.[ Price : $8.95]
CDER director Janet Woodcock says Howard Sklamberg will become director of the Centers Office of Compliance early next year.